PILLARS OF GROWTH
VCC MEDICAL DIVISION IS DEVELOPING CLINICALLY PROVEN PRODUCTS, SHOWN TO MAINTAIN REMISSION AND ALLEVIATE DISEASE
VCC-001 cancer vaccine Phase III data in Renal Cell Cancer has demonstrated clinical effect and was well tolerated, a disease with few current treatment options
VCC-001 cancer vaccine concept has significant potential in colon and pancreatic cancers
DE-RISKED BY REVENUE FROM MARKETED PRODUCTS IN PERSONALIZED MEDICINE DIVISION AND GMP CERTIFIED MANUFACTURING AND PRODUCTION SITE FBM-PHARMA
